Member Info for RuckRover

I agree with Konar.
There needs to be official, concise, accurate updates from the company.
Leaked emails followed by massive speculation isn’t quite the same.

"The share price is subject to economic forces as with all stocks worldwide"
This would of course be true if SCLP was valued on the basis of earnings and yield.
But if you believe the share is grossly undervalued, it is still grossly undervalued if the economy shrank 4%.
If people understood better the potential, perhaps it could be valued more accurately?

What's the film - Groundhog Day?

AB,
Thanks for posting the rules.

TF,
Fwiw, so do I. However there's no harm in being aware of ALL possibilities rather than blinkering yourself about all those that are unpalatable.

AB,
Based on what rule?

C11,
I know it was - ha ha.

C11,
Can you not get your head around the possibility that a real company with real people, real buildings, real science addressing real needs could actually have “no news” at the moment?

Alternatively, maybe there's just nothing to say?

AB,
Sorry been out all day.
"d To whom did C7 direct his negative post?"
Well that is the question isn't it. Logically it can't be you. Illogically it could be. .

AB,
I understand your desire for clarity on this but rather than harassing C7 for a reply maybe you could be happy working it out logically.

Bermuda asked if the comments were directed at him.
C7's reply was "of course not".
As you had stated exactly what Bermuda (and others) had, you can safely assume they were not directed at you.
Personally, I was arguing the opposite but as stated previously I fully understand the other view and have some sympathy for it.

Perhaps the important thing is to follow your own conscience and act accordingly.

Kashdog,

"I would like to think that Janey Godley’s Oncologist would be aware of all treatments and trials"

So would I but sadly I don't think that is true.
Knocking on someone's door to tell them their house is on fire would be "unsolicited".

I fully get both sides of the argument, it's a difficult one.

Think of it like this:

If you were away from home and walked past a house that was on fire, would you raise the alarm or just walk by since you "don't know them"?

I made a friend of mine who has terminal cancer aware of a trial (not Scancell btw). I didn't recommend it, I didn't give advice, merely made him aware there was a possible option.

The time for media coverage, PR and statements like "holy grail" was when Moditope was discovered, when pre-clinical data was published and when the trial was approved.

Now that we are "recruiting", the respect of privacy of the patients has to be priority. They have difficult medical decisions to make. These need to be made on an individual basis, based on medical fact not hype.

These considerations must come before any investor benefit imo.

Ray,
If you had stage 4 cancer and a terminal prognosis I think you may want to be first in the queue.

Violin,
Please don’t keep away from the keyboard. Publicising our misconceptions gives others the chance to put the record straight. That benefits us all.

Matt,

I'm not sure specific targets were mentioned other than "hard to treat" cancers of which pancreatic is one.

Cliff in this interview describes what the Scancell/BioNTech/Genetec/ISA collaboration was all about.....

https://www.youtube.com/watch?v=gBTaKD518yY

Burble,
I think the target was the £20m grant.

TF,
Sorry, my post was a little unclear. I didn't mean I thought the SP would fall when the FPD RNS lands. What I meant was, it it were to rise it would probably slip back to around where it was pre-RNS.

GF,
I don't think it will (have an impact on the SP). If it does, I think it will fall back. The real impact is when we get some DATA (positive of course). You may well be right, time will tell.

Regards
Gary.

"The confirmation that the drug is finally at work and no immediate negative effects have been recorded is a massive step forward in Moditope becoming the Cancer Vaccine we have all invested in."

Amen to that.